Medlines
Medlines
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know.  Medicine moves fast... So do we!
Sept. 4, 2026

Robots Can Draw Your Blood and Rethinking Statins After 70

Key Takeaways

  • The FDA has authorized Aletta, the first standalone blood-drawing robot that operates entirely without hands-on human intervention.
  • The Vitestro blood-drawing system utilizes near-infrared light and Doppler ultrasound to locate veins, achieving a 94.5% first-stick success rate.
  • A new clinical trial on atorvastatin in healthy adults over 70 revealed a 30% relative reduction in cardiovascular events, though without a significant gain in disability-free survival.
  • A single phlebotomist can safely supervise up to three autonomous Aletta units simultaneously, helping to alleviate staffing pressures in clinical settings.

Friday, September 4, 2026

In today's episode, Dr. Will Flanary (@drglaucomflecken) & Eva Johnson cover the FDA authorization of Aletta, the first standalone robot that draws blood without hands on operator intervention. The Vitestro system uses near infrared light and Doppler ultrasound to find veins, and one phlebotomist can supervise three units at a 94.5 percent first stick rate. They also break down a trial of atorvastatin in nearly 10,000 healthy adults over 70, where a 30 percent relative reduction in cardiovascular events came with no significant gain in disability free survival. Plus: new FDA decisions on skin and tobacco products, teen safety updates from Meta, and more.


Coverage Timeline:

(00:00) Intro

(01:00) Aletta: Autonomous Blood Draw Robot

(04:23) Statins for Healthy Older Adults

(07:19) Lysria for Dermatomyositis

(09:16) Ebola Vaccination & Slow Running


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.

Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources

Medlines is a Human Content Production

Frequently Asked Questions

What is the Aletta blood draw robot?

Aletta is the first FDA-authorized standalone robotic system that draws blood completely without hands-on operator intervention, using near-infrared light and Doppler ultrasound to find veins.

How accurate is the Aletta blood draw robot?

The system boasts an impressive 94.5 percent first-stick success rate, allowing one phlebotomist to supervise up to three units at the same time.

What did recent studies show about statins for adults over 70?

A trial of atorvastatin in nearly 10,000 healthy adults over 70 showed a 30 percent relative reduction in cardiovascular events, but no significant gain in disability-free survival.